Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
IBRX — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

38.93

Margin Of Safety %

Put/Call OI Ratio

0.37

EPS Next Q Diff

EPS Last/This Y

0.13

EPS This/Next Y

0.23

Price

6.99

Target Price

14.8

Analyst Recom

1

Performance Q

226.17

Upside

-295.6%

Beta

0.16

Ticker: IBRX



21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09IBRX8.440.400.26763532
2026-03-10IBRX7.990.400.39769124
2026-03-11IBRX8.270.400.57776769
2026-03-12IBRX7.820.410.51790566
2026-03-13IBRX7.820.410.50790566
2026-03-17IBRX8.270.420.10803304
2026-03-18IBRX8.570.410.19816775
2026-03-19IBRX8.810.410.20821952
2026-03-20IBRX8.480.410.33822281
2026-03-23IBRX9.380.360.20610390
2026-03-24IBRX7.410.360.97632765
2026-03-25IBRX8.060.390.26693657
2026-03-26IBRX7.360.390.34697900
2026-03-27IBRX7.360.390.27704405
2026-03-30IBRX6.660.370.13658565
2026-03-31IBRX7.650.360.33667905
2026-04-01IBRX7.160.360.34682169
2026-04-02IBRX7.30.370.23692756
2026-04-06IBRX7.090.360.38676020
2026-04-07IBRX6.840.360.21681422
2026-04-08IBRX6.990.370.15677493
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1



21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09IBRX8.4546.7-18.7-0.29
2026-03-10IBRX8.0046.7-11.1-0.29
2026-03-11IBRX8.2746.7-32.7-0.29
2026-03-12IBRX7.8346.7-11.0-0.29
2026-03-13IBRX8.3946.7-42.8-0.29
2026-03-17IBRX8.2153.3-26.0-0.25
2026-03-18IBRX8.5653.3-561.3-0.25
2026-03-19IBRX8.8153.3-32.1-0.25
2026-03-20IBRX8.4753.3-14.4-0.25
2026-03-23IBRX9.4053.3-52.0-0.25
2026-03-24IBRX7.4253.329.6-0.25
2026-03-25IBRX8.0753.3-46.9-0.25
2026-03-26IBRX7.3653.3-2.3-0.25
2026-03-27IBRX7.3753.3-24.8-0.25
2026-03-30IBRX6.6653.30.2-0.25
2026-03-31IBRX7.6453.3-62.3-0.25
2026-04-01IBRX7.1653.3-8.1-0.25
2026-04-02IBRX7.3053.3-29.6-0.25
2026-04-06IBRX7.0953.3-17.3-0.25
2026-04-07IBRX6.8853.3-17.0-0.25
2026-04-08IBRX6.9953.3-29.2-0.25
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1



21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09IBRX-0.077.2939.07
2026-03-10IBRX-0.077.2939.07
2026-03-11IBRX-0.077.2938.42
2026-03-12IBRX-0.077.2938.42
2026-03-13IBRX-0.077.2938.42
2026-03-17IBRX-0.077.2938.42
2026-03-18IBRX-0.077.2938.42
2026-03-19IBRX-0.077.2938.42
2026-03-20IBRX-0.077.2938.42
2026-03-23IBRX-0.077.2938.42
2026-03-24IBRX-0.077.2938.42
2026-03-25IBRX-0.077.2938.93
2026-03-26IBRX-0.077.2938.93
2026-03-27IBRX-0.077.2938.93
2026-03-30IBRX-0.077.2738.93
2026-03-31IBRX-0.077.2738.93
2026-04-01IBRX-0.077.2738.93
2026-04-02IBRX-0.077.2738.93
2026-04-06IBRX-0.077.2838.93
2026-04-07IBRX-0.077.2838.93
2026-04-08IBRX-0.077.2838.93
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

-0.06

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

-0.06

Insider Transactions

-0.07

Institutional Transactions

7.28

Beta

0.16

Average Sales Estimate Current Quarter

43

Average Sales Estimate Next Quarter

48

Fair Value

Quality Score

25

Growth Score

55

Sentiment Score

34

Actual DrawDown %

64.6

Max Drawdown 5-Year %

-93.5

Target Price

14.8

P/E

Forward P/E

PEG

P/S

63.34

P/B

P/Free Cash Flow

EPS

-0.39

Average EPS Est. Cur. Y​

-0.25

EPS Next Y. (Est.)

-0.02

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-310.18

Relative Volume

0.42

Return on Equity vs Sector %

42.9

Return on Equity vs Industry %

59.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

-29.2
◆ IBRX Healthcare
$6.98
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
14/20
Pullback
22/25
Volume
11/15
Valuation
12/20
TP/AR
4/10
Options
6/10
RSI
44.5
Range 1M
10.1%
Sup Dist
4.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
54 /100
WEAK
Momentum
6/25
Growth
26/30
Estimates
3/20
Inst/Vol
9/15
Options
10/10
EPS Yr
32.1%
EPS NY
77.8%
52W%
47.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +112% upside
Quality
7/30
Valuation
15/30
Growth
21/25
Stability
7/10
LT Trend
0/5
Upside
+112%
Quality
25
Click a card to see score breakdown Full Analysis →
ImmunityBio, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 684
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors; and 3M-052, a synthetic TLR7/8 agonist and 3M-052 formulations and related technology. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeOne Medicines Ltd. It has license agreement with 3M Innovative Properties Company and Access to Advanced Health Institute. ImmunityBio, Inc. is based in San Diego, California.
IBRX

Latest News

—
Caricamento notizie per IBRX…
stock quote shares IBRX – ImmunityBio, Inc. Stock Price stock today
news today IBRX – ImmunityBio, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IBRX – ImmunityBio, Inc. yahoo finance google finance
stock history IBRX – ImmunityBio, Inc. invest stock market
stock prices IBRX premarket after hours
ticker IBRX fair value insiders trading